On Sunday, Veja.com reported the UFC was withholding approximately $6 million from Anderson Silva (pictured) after the former middleweight champion tested positive for two performance-enhancing drugs.
The Brazilian outlet, which has been known to be a credible news source in the country, claimed the UFC was hanging onto Silva’s $600,000 fight purse from UFC 183, $200,000 win bonus for beating Nick Diaz in the January 31 event and his percentage of the show’s pay-per-view buys.
However, UFC officials promptly killed that chatter late last night.
“The financial reports made by Veja.com are not true,” the UFC expressed in a brief statement to MMAJunkie.com
The first significant hole in Veja’s claim is that the UFC is withholding Silva’s money. The MMA promotion can’t do that, only the athletic commission who oversaw the event can. In this case, it is the Nevada Athletic Commission, who have not done so.
Silva returned from a broken shin that kept him sidelined for 13 months to post a unanimous decision victory over Diaz in the card’s featured contest. The celebration was short-lived, because just three days later the NAC revealed Silva had flunked his pre-fight drug test for Drostanolone, an anabolic steroid, and Androsterone, a form of endogenous testosterone.
Silva now faces a fine, suspension and having his win overturned to a no contest. Most importantly, although “The Spider” has denied any wrongdoing, his illustrious career is forever tarnished.